Among primary ovarian cancer patients, the variables significantly associated with PFS (P < 0.05) in the univariate analysis included BRCA mutation/HRD status, absolute value of lymphocytes (AVOL), PARPi type, antibody-ABO, total bile acids (TBAs), fibrinogen concentration, and thrombin time. This evidence concerns the gene ABO and ovarian cancer.